- May 21, 2019Read more
The purpose of the Request for Information is to identify companies that have compounds in development that may be suitable candidates for inclusion in the PTSD Adaptive Platform Trial program at launch and who are interested to participate in the program.
- May 16, 2019Read more
We are excited to announce the speakers for the 2019 State of the Science Summit, including leaders in the field from organizations across government, industry, academia, clinical practice, and more.
- May 7, 2019Read more
The workshop sponsored by RAPID-Dx (Research Alliance for PTSD/TBI Innovation & Discovery Diagnostics) will convene experts from academia, government, and industry to discuss technological platforms for advancing biomarker discovery and development in PTSD and clinical co-presentations.
- April 8, 2019Read more
Cohen Veterans Bioscience announces findings from a study which identifies a critical brain imaging biomarker that may help guide people who suffer from PTSD towards the most effective treatment.